Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CVM

CEL SCI (CVM) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $1.94 -0.5% on the day -80.5% over 12 months 52-week range $0.97 – $10.11

Share price and insider trades

CVM closeInsider buyInsider sale
051015NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $49,998 on 2025-12-04 · Geert R KerstenBought $119,000 on 2026-05-13 · Geert R KerstenBought $138,000 on 2026-08-25 · Geert R KerstenBought $200,001 on 2026-01-22 · Geert R KerstenBought $360,000 on 2026-05-14 · Geert R Kersten
Bought, 12 months$867K
Sold, 12 months$0
Insiders buying1
Insiders selling0

CEL SCI insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $867K and 0 sold $0 of CVM stock on the open market.

CVM insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $50K bought (1 trades)$50KQ4 2025Q1 2026: $200K bought (1 trades)$200KQ1 2026Q2 2026: $479K bought (2 trades)$479KQ2 2026Q3 2026: $138K bought (1 trades)$138KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$138K1—0
Q2 2026$479K2—0
Q1 2026$200K1—0
Q4 2025$50K1—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$34.1MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day2.8×Last 5 sessions
Insiders' paper profit+$193KOn all tracked purchases +22.3%

Summary

Over the past 12 months, 1 CEL SCI CORP insider reported open-market purchases totaling $867K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Geert R Kersten (CEO) has the highest Insider Score at 10.

CVM stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 26SEC Geert R KerstenCEO Buy 100,000316,142 held (+46%) $1.38 $138K +40.6% 10
May 18SEC Geert R KerstenCEO Buy 300,000311,547 held (+2598%) $1.20 $360K +61.7% 10
May 14SEC Geert R KerstenCEO Buy 100,000222,497 held (+82%) $1.19 $119K +63.0% 10
Jan 26SEC Geert R KerstenCEO Buy 38,023120,815 held (+46%) $5.26 $200K -63.1% 10
Dec 5SEC Geert R KerstenCEO Buy 8,38981,794 held (+11%) $5.96 $50K -67.4% 10

Insiders at CEL SCI CORP

InsiderBoughtSoldLast filingScore
Geert R KerstenCEO $867K — Aug 26, 2026 10

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

CVM stock: common questions

Are CEL SCI CORP insiders buying CVM stock?

In the past 12 months, 1 insiders reported open-market purchases of CVM worth $867K. The latest was CEO Geert R Kersten bought $138K of CVM at $1.38 — raises the stake by 46%.

Are CEL SCI CORP insiders selling CVM stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CVM's 52-week range?

Over the past year CVM has traded between $0.97 and $10.11. It last closed at $1.94 on Oct 9, 2026.